The Management Board of PZ Cormay S.A. with its registered office in Łomianki ("Company"), with reference to information provided, among others in the consolidated quarterly report for the third quarter of 2018 published on November 14, 2018, informs that today, ie on December 14, 2018, the Company submitted the Hermes Senior hematology analyzer in the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland ("URPL"). After 14 days of making the application (in the absence of URPL reservations), the Company will be able to introduce the Hermes Senior hematology analyzer to trading on the Polish and European market (EU, EEA) and start the registration or registration procedure in the countries where it is required .
The Hermes Senior project is a project of strategic importance for the Company. In the opinion of the Management Board, commercialization of this device may have a significant impact on the Company's financial results.
Source: company website, investor relations, current and periodic reports.